Molecular diagnostics of bladder cancer.

Recruiting

• Conditions: bladder cancer; 10004994; urothelial carcinoma; 10038364

• Registration Number: NL-OMON30884
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

Patients diagnosed with bladder cancer

Exclusion Criteria

--

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The results of either no mutation or a mutation in FGFR3.<br /><br>There are 11 mutations known in FGFR3, which are analyzed simultaneously.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>n.v.t.</p><br>